Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation

Crippa, Fulvio; Corey, Lawrence; Sale, George; Boeckh, Michael; Chuang, Elaine L.
January 2001
Clinical Infectious Diseases;1/15/2001, Vol. 32 Issue 2, p214
Academic Journal
Presents information on a study which examined the prevalence of cytomegalovirus retinitis in hematopoietic stem cell transplantation patients in Seattle, Washington. Methodology; Results of the study; Discussion.


Related Articles

  • Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study. Moretti, S; Zikos, P; Van Lint, M T; Tedone, E; Occhini, D; Gualandi, F; Lamparelli, T; Mordini, N; Berisso, G; Bregante, S; Bruno, B; Bacigalupo, A // Bone Marrow Transplantation;7/15/98, Vol. 22 Issue 2, p175 

    This trial was designed to compare foscarnet with ganciclovir as pre-emptive therapy for CMV infection in patients undergoing allogeneic hemopoietic stem cell transplant (HSCT). Thirty-nine patients were randomized to receive foscarnet 90 mg/kg every 12 h (n = 20) or ganciclovir 5 mg/kg every 12...

  • Foscarnet.  // Reactions Weekly;May2014, Vol. 1500 Issue 1, p19 

    An abstract of the article "UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease," by K. Gregg and colleagues is presented.

  • Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Mori, T.; Mori, S.; Kanda, Y.; Yakushiji, K.; Mineishi, S.; Takaue, Y.; Gondo, H.; Harada, M.; Sakamaki, H.; Yajima, T.; Iwao, Y.; Hibi, T.; Okamoto, S. // Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p431 

    Summary:To evaluate the clinical significance of a cytomegalovirus (CMV) antigenemia assay in the prediction and diagnosis of CMV gastrointestinal (CMV-GI) disease after hematopoietic stem cell transplantation (HSCT), 19 allogeneic HSCT recipients developing CMV-GI disease were retrospectively...

  • Utility of antigenemia test for cytomegalovirus detection in hematopoietic transplant recipients: report of experiences from Medellin, Colombia. Sarmiento-Maldonado, M; Eugenia Castano-Orozco, M; Bedoya-Escobar, V I; Calle-Fernandez, S; Velasquez-Lopera, M; Gomez-Wolff, R; Karduss Urueta, A; Cuellar-Ambrosi, F // Bone Marrow Transplantation;Jul2003, Vol. 32 Issue 1, p119 

    Presents a study that investigated the use of the antigenemia pp65 test for the diagnosis of cytomegalovirus (CMV) infection in hematopoietic stem-cell transplant recipients at a hospital in Medellín, Colombia. Background on the blood samples used in the study; Analysis of the treatment...

  • Ganciclovir.  // Reactions Weekly;Jun2015, Vol. 1554 Issue 1, p94 

    An abstract of the article "Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping," by E. Drouot is presented.

  • Antiviral agent reduced cytomegalovirus disease after HSCT.  // Infectious Disease News;Oct2013, Vol. 26 Issue 10, p15 

    The article discusses a study published in a 2013 issue of the "New England Journal of Medicine" that examined the effectiveness of antiviral agent brincidofovir in reducing the risk for cytomegalovirus (CMV) disease in patients who underwent hematopoietic stem cell transplantation.

  • Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT. Król, L.; Stuchlý, J.; Hubáček, P.; Keslová, P.; Sedláček, P.; Starý, J.; Hrušák, O.; Kalina, T. // Bone Marrow Transplantation;Aug2011, Vol. 46 Issue 8, p1089 

    Depletion of cellular immunity as a consequence of conditioning before allogeneic hematopoietic SCT (HSCT) frequently results in CMV reactivation, which may in turn lead to life-threatening infections and require timely antiviral treatment. We have investigated the functional signatures of...

  • Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall. Noviello, M; Forcina, A; Veronica, V; Crocchiolo, R; Stanghellini, M T L; Carrabba, M; Greco, R; Vago, L; Giglio, F; Assanelli, A; Carbone, M R; Magnani, Z; Crippa, F; Corti, C; Bernardi, M; Peccatori, J; Bordignon, C; Ciceri, F; Bonini, C; Bondanza, A // Bone Marrow Transplantation;Sep2015, Vol. 50 Issue 9, p1262 

    The article presents a study which evaluates the early recovery of protective cytomegalovirus (CMV) immunity following an HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker against fungi and bacterial infections. It implies that CMV-specific T-cell responses by...

  • Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. von Bahr, L; Blennow, O; Alm, J; Björklund, A; Malmberg, K-J; Mougiakakos, D; Le Blanc, A; Oefner, P J; Labopin, M; Ljungman, P; Le Blanc, K // Bone Marrow Transplantation;Sep2015, Vol. 50 Issue 9, p1217 

    Vitamin D has emerged as a central player in the immune system, with its deficiency being implicated in the pathogenesis of several autoimmune diseases, including chronic GvHD. This is a retrospective cohort analysis of 166 patients, who underwent allogeneic hematopoietic stem cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics